AZ BioVentureHub, HB4
c/o AstraZeneca R&D Mölndal
Promimic is a biomaterial company founded in 2004 as a spin-off from research performed at Chalmers University of Technology in Gothenburg, Sweden. The company develops and markets a new generation of implant surface modifications and synthetic bone based on a patented method for production of nano sized hydroxyapatite. Promimic has an innovative and experienced organization that continuously is working on new ways to improve surface modification and coating of new materials.
CEO: Ulf Brogren
Please click here for Promimic job opportunities.